tradingkey.logo
搜索

Eikon Therapeutics Ord Shs

EIKN
添加自选
9.210USD
-0.410-4.26%
收盘 07-31 16:00美东报价延迟15分钟
498.62M总市值
亏损市盈率 TTM

Eikon Therapeutics Ord Shs

9.210
-0.410-4.26%

关于 Eikon Therapeutics Ord Shs 公司

Eikon Therapeutics Ord Shs简介

公司代码EIKN
公司名称Eikon Therapeutics Inc
上市日期Feb 05, 2026
CEOPerlmutter (Roger M)
员工数量384
证券类型Ordinary Share
年结日Feb 05
公司地址230 Harriet Tubman Way
城市MILLBRAE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94030
电话13026587581
网址https://eikontx.com/
公司代码EIKN
上市日期Feb 05, 2026
CEOPerlmutter (Roger M)

Eikon Therapeutics Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
Mr. Joshua Wolfe
Mr. Joshua Wolfe
Director
Director
--
--
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
Mr. Joshua Wolfe
Mr. Joshua Wolfe
Director
Director
--
--
,
,
--
--

常见问题

Eikon Therapeutics Ord Shs的前五大股东是谁?

Eikon Therapeutics Ord Shs 的前五大股东如下:Dr. Roger M. Perlmutter, M.D., Ph.D.
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有